Ann-Kathrin Eisfeld
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Acute Myeloid Leukemia Research 6
- Chronic Myeloid Leukemia Treatments 2
- Hematopoietic Stem Cell Transplantation 1
- Genetics 3
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Co-authors
- Clara D. Bloomfield (5 shared papers)Richard M. Stone (4 shared papers)Jessica Kohlschmidt (4 shared papers)Jonathan E. Kolitz (4 shared papers)Krzysztof Mrózek (3 shared papers)Eunice S. Wang (3 shared papers)Geoffrey L. Uy (2 shared papers)Richard A. Larson (2 shared papers)
- Journals
- Blood Advances (3 papers)Transplantation and Cellular Therapy (1 paper)Journal of Hematology & Oncology (1 paper)Genome Research (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Ann-Kathrin Eisfeld
6 papers receiving 141 citations
Peers
Comparison fields: 5 of 25
- Hematology 91
- Genetics 21
- Cancer Research 24
- Molecular Biology 77
- Immunology 11
Countries citing papers authored by Ann-Kathrin Eisfeld
This map shows the geographic impact of Ann-Kathrin Eisfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann-Kathrin Eisfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann-Kathrin Eisfeld more than expected).
Fields of papers citing papers by Ann-Kathrin Eisfeld
This network shows the impact of papers produced by Ann-Kathrin Eisfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann-Kathrin Eisfeld. The network helps show where Ann-Kathrin Eisfeld may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann-Kathrin Eisfeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 47 | |
| 2 | 2021 | 29 | |
| 3 | 2021 | 23 | |
| 4 | 2021 | 23 | |
| 5 | 2021 | 12 | |
| 6 | 2021 | 10 |
About Ann-Kathrin Eisfeld
Ann-Kathrin Eisfeld is a scholar working on Hematology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health and Infectious Diseases, having authored 6 papers that have together received 144 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Epigenetics and DNA Methylation (1 paper) and Hematopoietic Stem Cell Transplantation (1 paper). The work is most often cited by research in Hematology (91 citations), Genetics (21 citations), Cancer Research (24 citations), Molecular Biology (77 citations) and Immunology (11 citations). Ann-Kathrin Eisfeld has collaborated with scholars based in United States and Germany. Frequent co-authors include Clara D. Bloomfield, Richard M. Stone, Jessica Kohlschmidt, Jonathan E. Kolitz, Krzysztof Mrózek, Eunice S. Wang, Geoffrey L. Uy, Richard A. Larson, Guido Marcucci and Wendy Stock. Their work appears in journals such as Blood Advances, Transplantation and Cellular Therapy, Journal of Hematology & Oncology and Genome Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.